Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share (VTYX)

Historical Holders from Q4 2021 to Q3 2025

Symbol
VTYX on Nasdaq
CUSIP
92332V107
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
73M
All holders as of September 30, 2025
Q3 2025
Total 13F shares, excl. options
43.9M
Holdings value
$136M
% of all portfolios
0.001%
Grand Portfolio weight change
0%
Number of holders
109
Number of buys
50
Number of sells
-60
Average Value change %
0%
Average buys %
+0%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share (VTYX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
NSV Investments I, L.P. 7.6% $6.84M 5.43M Somasundaram Subramaniam Mar 10, 2025
Mohan Raju 6% $25.5M 4.38M Raju Mohan Nov 26, 2025
NSV Partners III LP 5.7% $5.15M 4.09M Subramaniam Somu Mar 28, 2025
Affinity Asset Advisors, LLC 5.7% $4.91M 4.06M Affinity Healthcare Fund, LP May 22, 2025
VANGUARD GROUP INC 5.28% $11.7M 3.77M The Vanguard Group Sep 30, 2025
Point72 Asset Management, L.P. 4.5% -47.5% $9.98M -$8.35M 3.21M -45.6% Point72 Asset Management, L.P. Sep 30, 2025
Sio Capital Management, LLC 3.63% -34.8% $3.25M -$1.84M 2.58M -36.2% Sio Capital Management, LLC Mar 31, 2025
CITADEL ADVISORS LLC 2% $1.78M 1.41M Kenneth Griffin Mar 31, 2025
BlackRock, Inc. 1.9% $2.89M 1.35M BlackRock, Inc. Jun 30, 2025
BANK OF AMERICA CORP /DE/ 1.4% -72.9% $1.28M -$4.54M 1.02M -78% BANK OF AMERICA CORP /DE/ Mar 31, 2025
Flynn James E 0.76% $674K 535K Deerfield Mgmt, L.P. Dec 31, 2024

Institutional Holders of Ventyx Biosciences, Inc. - Common Stock, par value $0.0001 per share (VTYX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 43.9M $136M -$468K $3.11 109
2025 Q2 44.4M $95.1M +$2.06M $2.14 112
2025 Q1 44.4M $51.1M -$13.7M $1.15 116
2024 Q4 54.4M $119M +$4.1M $2.19 122
2024 Q3 52.5M $114M -$11.8M $2.18 115
2024 Q2 56.9M $132M -$36.6M $2.31 113
2024 Q1 58.8M $323M +$111M $5.50 121
2023 Q4 43.2M $107M -$553M $2.47 119
2023 Q3 54.6M $1.9B +$62.3M $34.73 141
2023 Q2 52.6M $1.73B +$92.8M $32.80 149
2023 Q1 49.7M $1.67B +$244M $33.50 144
2022 Q4 42.3M $1.39B +$101M $32.79 121
2022 Q3 39.3M $1.37B +$167M $34.91 103
2022 Q2 34.6M $424M +$17M $12.23 58
2022 Q1 33.2M $448M +$21.6M $13.57 53
2021 Q4 30.7M $601M +$601M $19.86 45